Each prostate-cancer treatment was associated with a distinct pattern of change in quality-of-life domains related to urinary, sexual, bowel, and hormonal function. These changes influenced satisfaction with treatment outcomes among patients and their spouses or partners.
Aneurysms involving the splanchnic arteries represent an uncommon and potentially lethal form of vascular disease. Because they frequently present as life-threatening clinical emergencies, a clear understanding of the presentation and management of these aneurysms is essential for the practicing vascular surgeon. The purpose of this review was to document recent changes in the diagnosis and management of common splanchnic artery aneurysms. Traditionally the most commonly reported splanchnic artery aneurysms have involved, in decreasing order of frequency, the splenic, hepatic, and celiac arteries.~ We reviewed the English language literature for the past 10 years (1985 to 1995) for reports of these lesions. Interestingly, in contrast to previously published series, aneurysms of the hepatic arteries were the most frequently reported splanchnic artery aneurysms in the past decade. This trend probably relates to the increasing use of percutaneous diagnostic and therapeutic biliary tract procedures. During these procedures, injury to the intrahepatic branches of the hepatic artery can lead to the development of false aneurysms of these vessels. In addition to these iatrogenic false aneurysms, the increased use of diagnostic CT scanning following blunt liver trauma has also led to increased detection of posttraumatic false aneurysms of the intrahepatic arterial
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.